Managing Global Supplies

Vaccine trials require accurate drug supply forecasting and a dynamic supply chain to support sites in regions where virus prevalence changes quickly. That's why companies such as AstraZeneca save 10%+ annually from their drug supply budget by transforming forecasting and supply chain efficiency with Signant.

Efficient Patient Data Capture

With hundreds or thousands of patients reporting symptoms typically for 7-14 days after vaccine intervention, you need eCOA to capture high volumes of trustworthy and time-stamped data, receive real-time alerts of potential AE indicators, and eliminate the costly transcription errors and delays inherent with paper.

Compliance and Retention

Patients in vaccine trials have a lot to think about. That's why we offer econsent and patient concierge solutions alongside eCOA. This ensures patients fully understand their study commitment and keeps your trial top of mind to support compliance and completion.

WHEN PFIZER NEEDED eCOA ASAP, WE ANSWERED THE CALL

VACCINE TRIALS
Helping you overcome key challenges

Whether you’re developing new vaccines for RSV, CMV, chickengunya, Lyme’s disease, COVID-19, or hantavirus, count on Signant to help you generate high quality evidence for submission.

LET'S WORK TOGETHER

When the world is counting on you - count on Signant

 REIMAGINE THE PATH TO PROOF

40,000  PATIENTS

6
COUNTRIES

17
LANGUAGES

5
WEEKS

163
SITES

RAPID ENROLLMENT

With hundreds or thousands of patients reporting symptoms typically for 7-14 days after vaccine intervention, you need eCOA to capture high volumes of trustworthy and time-stamped data, receive real-time alerts of potential AE indicators, and eliminate the costly transcription errors and delays inherent with paper.